Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Phytotherapy Research

Efficacy and Safety of Curcumin as an Adjuvant to Standard Chemotherapy in Advanced and Metastatic Breast Cancer Patients: A Randomized Controlled Study

View Full Paper
Ask AI
Bookmark
Share

Authors

SGShekhar GoyalSBSurender BeniwalPAPallavi Agarwal

Discussion

Loading...

Member takes

Overview

Randomized controlled trial shows curcumin improves objective response rate and quality of life in breast cancer patients, suggesting it can serve as an effective adjuvant.

Key Points

  • Curcumin significantly improved the objective response rate compared to standard chemotherapy.
  • After 12 weeks, patients receiving curcumin showed a notable progression-free survival advantage.
  • The study involved 120 women with locally advanced or metastatic breast cancer, tested with curcumin and chemotherapy.
  • Implementing curcumin in treatment regimens may lead to improved quality of life and fewer adverse effects.

Cite This Study

Goyal et al. (2025) studied this question.

synapsesocial.com/papers/68c23b8fb210217d64785192https://doi.org/10.1002/ptr.70086
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The synergistic anticancer effects of curcumin in combination with breast cancer chemotherapy drugs2025
  2. 2IMPROVING QUALITY OF LIFE IN LOCALLY ADVANCED OR ADVANCED HEAD AND NECK CANCER WITH CURCUMIN ADD-ON TO STANDARD NUTRITION SUPPORT: A SECONDARY ANALYSIS OF THE CURCHEXIA STUDY2025
  3. 3Research progress on the impact of curcumin on immune responses in breast cancer2025
  4. 4The Pro-Apoptotic Effects of Curcumin on HCT116 Colorectal Cancer Cells2025
  5. 5Effect of curcumin on fatigue and musculoskeletal health in postmenopausal women: a double-blind randomised controlled trial2025